CRISPR, Viking, Fate, Molecular Templates price follow-ons

CRISPR Therapeutics AG (NASDAQ:CRSP), Viking Therapeutics Inc. (NASDAQ:VKTX), Fate Therapeutics Inc. (NASDAQ:FATE) and Molecular Templates Inc. (NASDAQ:MTEM) each priced follow-ons late on Sept. 20, raising a total of $545.9 million.

CRISPR raised $200 million through the sale of 4.2 million shares at $47.50 in

Read the full 433 word article

User Sign In